6,7-dihydroxy Bergamottin
(Synonyms: 二羟基香柠檬素,6,7-DHB) 目录号 : GC11864A potent CYP3A4 inhibitor
Cas No.:145414-76-2
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
IC50: 25 μM
6,7-dihydroxy Bergamottin, also known as 6,7-DHB, is a potent inhibitor of cytochrome P4503A4 (CYP3A4) with an IC50 value of 25 μM. As a primary compound in grapefruit juice, 6,7-DHB is responsible for the blockade the activity of testosterone 6β-hydrolase.
CYP3A4 is an important enzyme, mainly found in both the intestinal wall and liver, which oxidizes small foreign organic molecules (xenobiotics), such as toxins or drugs.
In vitro: 6,7-DHB significantly blocked the testosterone 6β-hydrolase in human liver microsomes and human CYP3A4 expressed in Escherichia coli membrane in a time- and concentration-dependent manner. Furthermore, 6,7-DHB proved to be a potent NADPH- and time-dependent inhibitor of CYP3A4 [1]. 6,7-DHB concentration-dependently inhibited nifedipine (NFP) oxidation in HepG2-GS-3A4 cell, a cell line from hepatoblastoma with overexpression of human CYP3A4 [2].
In vivo: Male Wistar-ST rats were intraduodenally administered with 6,7-DHB at a dose of 3.4 mg/ml. After 4 hours, 6,7-DHB had no significant effects on the NFP plasma concentrations, suggesting that 6,7-DHB had no pharmacokinetic effect on the rats [3].
References:
[1]. Bellevue, F., Woster, P., Edwards, D., He, K., & Hollenberg, P. Synthesis and biological evaluation of 6′,7′-dihydroxybergamottin (6,7-DHB), a naturally occurring inhibitor of cytochrome P450 3A4. Bioorganic & Medicinal Chemistry Letters. 1997; 7(20): 2593-2598.
[2]. Araki, N., Tsuruoka, S., Hasegawa, G., Yanagihara, H., Omasa, T., & Enosawa, S. et al. Inhibition of CYP3A4 by 6′,7′-dihydroxybergamottin in human CYP3A4 over-expressed hepG2 cells. Journal of Pharmacy and Pharmacology. 2012; 64(12): 1715-1721.
[3]. Mohri, K., & Uesawa, Y. Effects of Furanocoumarin Derivatives in Grapefruit Juice on Nifedipine Pharmacokinetics in Rats. Pharmaceutical Research, 2001;18(2):177-182.
| Cas No. | 145414-76-2 | SDF | |
| 别名 | 二羟基香柠檬素,6,7-DHB | ||
| 化学名 | 4-[[(2E)-6,7-dihydroxy-3,7-dimethyl-2-octenyl]oxy]-7H-fuoro[3,2-g][1]benzopyran-7-one | ||
| Canonical SMILES | O=C1C=CC2=C(OC/C=C(C)/CCC(O)C(C)(O)C)C3=C(OC=C3)C=C2O1 | ||
| 分子式 | C21H24O6 | 分子量 | 372.4 |
| 溶解度 | ≤10mg/ml in ethanol;30mg/ml in DMSO;30mg/ml in dimethyl formamide | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 2.6853 mL | 13.4264 mL | 26.8528 mL |
| 5 mM | 0.5371 mL | 2.6853 mL | 5.3706 mL |
| 10 mM | 0.2685 mL | 1.3426 mL | 2.6853 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。